917834-41-4

Upstream product

• 1187321-31-8 4-benzyloxycarbonylaminopiperidine-1,4-dicarboxylic acid-1-tert-butyl ester-4-ethyl ester 
• 1187321-32-9 4-aminopiperidine-1,4-dicarboxylic acid-1-tert-butyl ester-4-ethyl ester 
• 1093214-64-2 1-(tert-butoxycarbonyl)-4-(ethoxycarbonyl)piperidine-4-carboxylic acid 
• 288154-16-5 4-(Benzyloxycarbonylamino)-1-(tert-butoxycarbonyl)-piperidine-4-carboxylic Acid 
• 183673-68-9 1-tert-butyloxycarbonylpiperidine-4-spiro-5'-(1',3'-bis(tertbutyloxy-carbonyl))hydantoin 
• 183673-70-3 tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 203186-96-3 tert-butyl 4-amino-4-(hydroxymethyl)piperidine-1-carboxylate 
• 501-53-1 benzyl chloroformate 
• 392331-67-8 1-(tert-butyl) 4-methyl 4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)piperidine-1,4-dicarboxylate 

Downstream Products

• 1091681-76-3 4-benzyloxycarbonylamino-4-chloromethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1187321-34-1 tert-butyl 4-(benzyloxycarbonylamino)-4-(fluoromethyl)piperidine-1-carboxylate 
• 1091681-78-5 4-benzyloxycarbonylamino-4-(4-fluoro-benzyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1091681-82-1 [1-((S)-2-tert-butoxycarbonylamino-3,3-dimethyl-butyryl)-4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester 
• 1091681-80-9 [4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester hydrochloride 
• 1091682-14-2 (R)-N-{(S)-1-[4-amino-4-(4-fluoro-benzyl)-piperidine-1-carbonyl]-2,2-dimethyl-propyl}-2-cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionamide 
• 1091681-74-1 [1-((S)-2-amino-3,3-dimethyl-butyryl)-4-(4-fluoro-benzyl)-piperidin-4-yl]-carbamic acid benzyl ester hydrochloride 
• 1091682-16-4 {1-{(S)-2-[(R)-3-(benzyloxyl-formyl-amino)-2-cyclopentylmethyl-propionylamino]-3,3-dimethy-butyryl}-4-(4-fluoro-benzyl)-piperidin-4-yl}-carbamic acid benzyl ester 
• 1187321-35-2 (4-fluoromethylpiperidin-4-yl)carbamic acid benzyl ester 

Relevant academic research and scientific papers

SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.

NOVEL DERIVATIVES OF ACYL CYANOPYRROLIDINES

A compound of formula (I) or a tautomeric form, regioisomer, stereoisomer, solvate, N-oxide or pharmaceutically acceptable salts thereof; wherein 'a' - is selected from the group consisting of substituted or unsubstituted heterocycloalkyl ring and substituted or unsubstituted carbohydrate moiety y is a member selected from -O-, -CO-, -S02-, aminoalkyl or formula (II) wherein, Rw is hydrogen, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl; x is a member selected from -0-, -S-, -SO-, -S02-, CONR10, NR10CO and -NRd-, or x and y together represent a chemical bond; Z is selected from -CH-, -N-. t is an integer selected from O to 4; with the provisos that when 'a' is substituted or unsubstituted heterocycloalkyl ring then 't' is not O and when y = -CO-, x is not NRd.

A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.